Patents by Inventor Elodie Burty

Elodie Burty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN EPITHELIAL CELL LINE FOR 3-D MODELIZING OF CANCER AND TREATMENT THEREOF
    Publication number: 20190242874
    Abstract: A cellular model is described that targets dysregulation or inappropriate activation of the Sonic Hedgehog/Patched (SHH/PTCH) pathway. Also described is a screening method using this cellular model to screen for pharmacological compounds that can treat or prevent skin cancer, in particular, Basal Cell Carcinoma (BCC) lesions.
    Type: Application
    Filed: October 10, 2018
    Publication date: August 8, 2019
    Inventors: Elodie Burty, Thierry Magnaldo, Yannick Gache, Jérôme Aubert
  • SYSTEM FOR ANALYSIS AND ACTIVATION AND/OR LOCALISED RELEASE FOR THE HUMAN FACE
    Publication number: 20180352937
    Abstract: The invention relates to a system for analysis and activation and/or active and localised release, comprising a mask (1) for applying to at least part of the face of the user, provided with at least one device (2) for analysing the skin of the face and at least one means for the active and localised release (3) of dermocosmetic formulations from at least one storage means.
    Type: Application
    Filed: September 4, 2015
    Publication date: December 13, 2018
    Applicant: WB Technologies
    Inventors: Stanislas Vandier, Elodie Burty-Valin, Benjamin Prunier, Jean-Roch Meunier, Jean-François Grollier, Claude Dubief
  • Human keratinocytes PTCH1 cell line
    Patent number: 9902934
    Abstract: A cellular model is described for targeting dysregulation or inappropriate activation of the Sonic Hedgehog/Patched (SHH/PTCH) pathway. Also described, is a screening method using this cellular model to screen for pharmacological compounds that can treat or prevent skin cancer and, in particular, Basal Cell Carinoma (BCC) lesions.
    Type: Grant
    Filed: September 24, 2012
    Date of Patent: February 27, 2018
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Elodie Burty, Thierry Magnaldo, Yannick Gache
  • HUMAN EPITHELIAL CELL LINE FOR 3-D MODELIZING OF CANCER AND TREATMENT THEREOF
    Publication number: 20170023549
    Abstract: A cellular model is described that targets dysregulation or inappropriate activation of the Sonic Hedgehog/Patched (SHH/PTCH) pathway. Also described, is a screening method using this cellular model to screen for pharmacological compounds that can treat or prevent skin cancer, in particular, Basal Cell Carcinoma (BCC) lesions.
    Type: Application
    Filed: February 25, 2016
    Publication date: January 26, 2017
    Inventors: Elodie BURTY, Thierry MAGNALDO, Yannick GACHE, Jérôme AUBERT
  • HUMAN EPITHELIAL CELL LINE FOR 3-D MODELIZING OF CANCER AND TREATMENT THEREOF
    Publication number: 20140243523
    Abstract: A cellular model is described that targets dysregulation or inappropriate activation of the Sonic Hedgehog/Patched (SHH/PTCH) pathway. Also described, is a screening method using this cellular model to screen for pharmacological compounds that can treat or prevent skin cancer, in particular, Basal Cell Carcinoma (BCC) lesions.
    Type: Application
    Filed: September 24, 2012
    Publication date: August 28, 2014
    Applicants: GALDERMA RESEARCH & DEVELOPMENT, CNRS
    Inventors: Elodie Burty, Thierry Magnaldo, Yannick Gache, Jérôme Aubert
  • FIBROBLASTS CELLULAR MODEL FOR ASSESSING EFFICACY OF CANCER TREATMENTS BY SHH/PTCH PATHWAY ANTAGONISTS
    Publication number: 20140235856
    Abstract: A cellular model is described that targets dysregulation or inappropriate activation of the Sonic Hedgehog/Patched (SHH/PTCH) pathway. Also described, is a screening method using this cellular model to screen for pharmacological compounds that can treat or prevent skin cancer, in particular, Basal Cell Carcinoma, (BCC) lesions.
    Type: Application
    Filed: September 24, 2012
    Publication date: August 21, 2014
    Inventors: Elodie Burty, Thierry Magnaldo, Yannick Gache
  • HUMAN KERATINOCYTES PTCH1 CELL LINE
    Publication number: 20140234852
    Abstract: A cellular model is described for targeting dysregulation or inappropriate activation of the Sonic Hedgehog/Patched (SHH/PTCH) pathway. Also described, is a screening method using this cellular mod& to screen for pharmacological compounds that can treat or prevent skin cancer and, in particular, Basal Cell Carinoma (BCC) lesions.
    Type: Application
    Filed: September 24, 2012
    Publication date: August 21, 2014
    Applicants: GALDERMA RESEARCH & DEVELOPMENT, CNRS
    Inventors: Elodie Burty, Thierry Magnaldo, Yannick Gache